Renal Dialysis Equipment Market

Executive Summary

Renal Dialysis Equipment Market was valued at US $82.37 billion in 2021 and is projected to grow at 7.11% CAGR over the forecast period to reach US $124.42 billion by 2027. Renal Dialysis Equipment Market represented US $10.58 billion opportunity over 2019-2021 and estimated to create US $42.05 billion opportunity in 2027 over 2021.

Renal Dialysis Equipment from Consainsights analyses the Renal Dialysis Equipment Market in the Life Sciences industry over the forecast period to 2027.

Renal Dialysis Equipment research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Renal Dialysis Equipment segmentation includes Product Type, Application, End User and Geography.

Based on the Product Type, the Renal Dialysis Equipment analysis covers Hemodialysis (HD) Equipment, Peritoneal Dialysis (PD) Equipment, Concentrates and Solutions, Catheters and Tubings, Other Products.

In Product Type segment, Hemodialysis (HD) Equipment segment has highest cagr growth of 6.30%.

Based on the Application, the Renal Dialysis Equipment analysis covers Hemodialysis, Peritoneal Dialysis.

In Application segment, Hemodialysis segment has highest cagr growth of 6.30%.

Based on the End User, the Renal Dialysis Equipment analysis covers In-Center Dialysis Settings, Home Care Settings.

In End User segment, In-Center Dialysis Settings segment has highest cagr growth of 6.30%.

Based on the region, the Renal Dialysis Equipment analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Fresenius Kabi AG, Baxter International, Inc., Nipro Corporation, B. Braun Melsungen AG, Nikkiso Co. Ltd, Asahi Kasei Corporation, Medtronic PLC, Rockwell Medical, Teleflex Incorporated, Allmed Medical Care Holdings Limited, Medivators Inc, Toray Medical Co. Ltd, Hemoclean Co. Ltd, Quanta, Outset Medical Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product Type

Introduction

In 2021, Hemodialysis (HD) Equipment segment has the highest revenue of US $34.68 billion and is expected to grow at CAGR of 6.30% by 2027 Hemodialysis (HD) Equipment segment has highest cagr growth of 6.30%.

Hemodialysis (HD) Equipment

Hemodialysis (HD) Equipment segment was valued at US $30.23 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $52.39 billion by 2027. Hemodialysis (HD) Equipment segment represented US $4.45 billion opportunity over 2019-2021 and estimated to create US $17.70 billion opportunity in 2027 over 2021.

Peritoneal Dialysis (PD) Equipment

Peritoneal Dialysis (PD) Equipment segment was valued at US $18.82 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $32.62 billion by 2027. Peritoneal Dialysis (PD) Equipment segment represented US $2.77 billion opportunity over 2019-2021 and estimated to create US $11.02 billion opportunity in 2027 over 2021.

Concentrates and Solutions

Concentrates and Solutions segment was valued at US $8.82 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $15.28 billion by 2027. Concentrates and Solutions segment represented US $1.30 billion opportunity over 2019-2021 and estimated to create US $5.16 billion opportunity in 2027 over 2021.

Catheters and Tubings

Catheters and Tubings segment was valued at US $7.77 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $13.47 billion by 2027. Catheters and Tubings segment represented US $1.15 billion opportunity over 2019-2021 and estimated to create US $4.55 billion opportunity in 2027 over 2021.

Other Products

Other Products segment was valued at US $6.15 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $10.66 billion by 2027. Other Products segment represented US $0.91 billion opportunity over 2019-2021 and estimated to create US $3.60 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Hemodialysis segment has the highest revenue of US $50.89 billion and is expected to grow at CAGR of 6.30% by 2027 Hemodialysis segment has highest cagr growth of 6.30%.

Hemodialysis

Hemodialysis segment was valued at US $44.35 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $76.86 billion by 2027. Hemodialysis segment represented US $6.54 billion opportunity over 2019-2021 and estimated to create US $25.97 billion opportunity in 2027 over 2021.

Peritoneal Dialysis

Peritoneal Dialysis segment was valued at US $27.44 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $47.55 billion by 2027. Peritoneal Dialysis segment represented US $4.04 billion opportunity over 2019-2021 and estimated to create US $16.07 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, In-Center Dialysis Settings segment has the highest revenue of US $58.50 billion and is expected to grow at CAGR of 6.30% by 2027 In-Center Dialysis Settings segment has highest cagr growth of 6.30%.

In-Center Dialysis Settings

In-Center Dialysis Settings segment was valued at US $50.99 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $88.36 billion by 2027. In-Center Dialysis Settings segment represented US $7.51 billion opportunity over 2019-2021 and estimated to create US $29.86 billion opportunity in 2027 over 2021.

Home Care Settings

Home Care Settings segment was valued at US $20.81 billion in 2019 and is projected to grow at 6.30% CAGR over the forecast period to reach US $36.06 billion by 2027. Home Care Settings segment represented US $3.07 billion opportunity over 2019-2021 and estimated to create US $12.19 billion opportunity in 2027 over 2021.